SciBase Secures SEK 20 Million Loan from Castle Biosciences
Reuters
Nov 07
SciBase Secures SEK 20 Million Loan from <a href="https://laohu8.com/S/CSTL">Castle Biosciences</a>
SciBase Holding AB has expanded its collaboration and license agreement with Castle Biosciences and entered into a new loan agreement. Under the terms, Castle Biosciences will provide SciBase with a five-year loan totaling SEK 20 million. The loan carries an interest rate of STIBOR plus 2% per annum, with interest payments due quarterly starting March 31, 2026. The loan is to be repaid in cash within five years, or, at Castle's request, may be converted into new SciBase shares at a price based on the volume weighted average price over the 30 trading days preceding repayment. The loan is secured by a share pledge over SciBase's shares in SciBase AB. The funding will support SciBase's production ramp-up and continued growth, particularly in skin barrier health and skin cancer diagnostics.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SciBase Holding AB published the original content used to generate this news brief on November 07, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.